Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

October 31, 2009

Conditions
Duodenal Ulcer
Interventions
DRUG

5 mg ilaprazole

One 5-mg ilaprazole tablet (Livzon Pharm Group Inc., China) together with three placebo tablets and one placebo capsule in a package being taken orally each

DRUG

10 mg ilaprazole

Two 5-mg ilaprazole tablets (Livzon Pharm Group Inc., China) together with two placebo tablets and one placebo capsule in a package being taken orally each morning on an empty stomach for 4 weeks

DRUG

10 mg Rabeprazole

one 10-mg Rabeprazole tablets together with one placebo capsule in a package being taken orally each morning on an empty stomach for 4 weeks

All Listed Sponsors
lead

Livzon Pharmaceutical Group Inc.

INDUSTRY